USPTO serial 87015102
SICKLE CELL APPROVED
Reviewed by CopyMark Law Group
Reg. 5498358Status 710
- Filing date
- Status date
- Registration date
- Jun 19, 2018
- Examiner
- SIMCOX, KYLE DUNCAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with SICKLE CELL APPROVED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tammy Hui
Tammy Hui THE GELLER LAW GROUP PLLC4000 Legato Rd., Suite 1100Fairfax, VA 22033UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 041 | arranging of seminars; charitable donation services, namely, providing educational classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases; conducting workshops and seminars in the field of sickle cell disease and other blood-borne illnesses/diseases; education services, namely, providing live and on-line classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases; education services, namely, providing non-downloadable webinars in the field of sickle cell disease and other blood-borne illnesses/diseases; education services, namely, providing on-line classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases; education services, namely, providing classes, seminars, workshops, and training in the fields of sickle cell disease and other blood-borne illnesses/diseases; education services, namely, training educators in the field of sickle cell disease and other blood-borne illnesses/diseases and providing curricula in connection therewith; educational services, namely, conducting classes, seminars, conferences, workshops, retreats, camps and field trips in the field of sickle cell disease and other blood-borne illnesses/diseases and distribution of training material in connection therewith; educational services, namely, conducting informal on-line programs in the fields of sickle cell disease and other blood-borne illnesses/diseases, and printable materials distributed therewith; educational services, namely, conducting informal programs in the fields of sickle cell disease and other blood-borne illnesses/diseases, using on-line activities and interactive exhibits, and printable materials distributed therewith; educational services, namely, conducting programs in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, conducting classes, seminars, workshops, and training for parents, instructors, companies, and caretakers of individuals with sickle cell disease and other blood-borne illnesses in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, conducting classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases and distribution of training material in connection therewith; educational services, namely, conducting classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, developing curriculum for others in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, providing displays and exhibits in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, providing educational speakers in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, providing online instruction in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, providing online instruction in the field of sickle cell disease and other blood-borne illnesses/diseases via an online website; educational services, namely, providing classes, seminars, workshops, and training in the fields of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, teacher training in the field of sickle cell disease and other blood-borne illnesses/diseases provided on a real-time basis during classroom instruction; organization of seminars; providing classes, workshops, seminars and camps in the field of sickle cell disease and other blood-borne illnesses/diseases; providing on-line training classes, seminars, and workshops in the field of sickle cell disease and other blood-borne illnesses/diseases; training services in the field of sickle cell disease and other blood-borne illnesses/diseases; workshops and seminars in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, conducting on line and telephonic instruction and courses in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, conducting on-line exhibitions and displays and interactive exhibits in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, conducting classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases and distribution of course materials in connection therewith in printed or electronic format; educational services, namely, conducting classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases and distribution of course material in connection therewith; educational services, namely, conducting classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases and distribution of course and educational materials in connection therewith ; educational services, namely, conducting classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases and distribution of educational materials in connection therewith; educational services, namely, developing, arranging, and conducting educational conferences and programs and providing courses of instruction in the field of sickle cell disease and other blood-borne illnesses/diseases | SECTION 8 - CANCELLED | Mar 12, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 3, 2025 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jun 19, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 27, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 27, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 27, 2021 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| May 27, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 27, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 27, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 19, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 17, 2018 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| May 16, 2018 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 11, 2018 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 4, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 16, 2018 | IUAF | USE AMENDMENT FILED | — |
| Apr 16, 2018 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Nov 23, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 21, 2017 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 21, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 21, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 30, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 4, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 4, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 15, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 21, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 16, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 16, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 16, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 16, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 19, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 10, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 29, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 29, 2016 | NWAP | NEW APPLICATION ENTERED | — |